Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Adaptive Radiotherapy for Glioblastoma Multiforme – The Impact on Disease Outcome

ZOLTÁN VÉGVÁRY, BARBARA DARÁZS, VIKTOR PACZONA, ÁGNES DOBI, ZITA REISZ, ZOLTÁN VARGA, EMESE FODOR, ADRIENN CSERHÁTI, JUDIT OLÁH, DÁVID KIS, PÁL BARZÓ and KATALIN HIDEGHÉTY
Anticancer Research August 2020, 40 (8) 4237-4244; DOI: https://doi.org/10.21873/anticanres.14425
ZOLTÁN VÉGVÁRY
1Department of Oncotherapy, University of Szeged, Szeged, Hungary
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
BARBARA DARÁZS
1Department of Oncotherapy, University of Szeged, Szeged, Hungary
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: darazsb{at}gmail.com
VIKTOR PACZONA
1Department of Oncotherapy, University of Szeged, Szeged, Hungary
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ÁGNES DOBI
1Department of Oncotherapy, University of Szeged, Szeged, Hungary
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ZITA REISZ
3Department of Pathology, University of Szeged, Szeged, Hungary
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ZOLTÁN VARGA
1Department of Oncotherapy, University of Szeged, Szeged, Hungary
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
EMESE FODOR
1Department of Oncotherapy, University of Szeged, Szeged, Hungary
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ADRIENN CSERHÁTI
1Department of Oncotherapy, University of Szeged, Szeged, Hungary
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JUDIT OLÁH
1Department of Oncotherapy, University of Szeged, Szeged, Hungary
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DÁVID KIS
4Department of Neurosurgery, University of Szeged, Szeged, Hungary
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PÁL BARZÓ
4Department of Neurosurgery, University of Szeged, Szeged, Hungary
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KATALIN HIDEGHÉTY
1Department of Oncotherapy, University of Szeged, Szeged, Hungary
2ELI-ALPS Non-profit Ltd, Szeged, Hungary
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 40 no. 8 4237-4244
DOI 
https://doi.org/10.21873/anticanres.14425
PMID 
32727750

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received June 2, 2020
  • Revision received June 24, 2020
  • Accepted June 27, 2020
  • Published online July 29, 2020.

Copyright & Usage 
Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

Author Information

  1. ZOLTÁN VÉGVÁRY1,
  2. BARBARA DARÁZS1⇑,
  3. VIKTOR PACZONA1,
  4. ÁGNES DOBI1,
  5. ZITA REISZ3,
  6. ZOLTÁN VARGA1,
  7. EMESE FODOR1,
  8. ADRIENN CSERHÁTI1,
  9. JUDIT OLÁH1,
  10. DÁVID KIS4,
  11. PÁL BARZÓ4 and
  12. KATALIN HIDEGHÉTY1,2
  1. 1Department of Oncotherapy, University of Szeged, Szeged, Hungary
  2. 2ELI-ALPS Non-profit Ltd, Szeged, Hungary
  3. 3Department of Pathology, University of Szeged, Szeged, Hungary
  4. 4Department of Neurosurgery, University of Szeged, Szeged, Hungary
  1. Correspondence to: Barbara Darázs, Department of Oncotherapy, University of Szeged, Szeged, Hungary. E-mail: darazsb{at}gmail.com
View Full Text

Statistics from Altmetric.com

Cited By...

  • 9 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 40, Issue 8
August 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Adaptive Radiotherapy for Glioblastoma Multiforme – The Impact on Disease Outcome
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Adaptive Radiotherapy for Glioblastoma Multiforme – The Impact on Disease Outcome
ZOLTÁN VÉGVÁRY, BARBARA DARÁZS, VIKTOR PACZONA, ÁGNES DOBI, ZITA REISZ, ZOLTÁN VARGA, EMESE FODOR, ADRIENN CSERHÁTI, JUDIT OLÁH, DÁVID KIS, PÁL BARZÓ, KATALIN HIDEGHÉTY
Anticancer Research Aug 2020, 40 (8) 4237-4244; DOI: 10.21873/anticanres.14425

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Adaptive Radiotherapy for Glioblastoma Multiforme – The Impact on Disease Outcome
ZOLTÁN VÉGVÁRY, BARBARA DARÁZS, VIKTOR PACZONA, ÁGNES DOBI, ZITA REISZ, ZOLTÁN VARGA, EMESE FODOR, ADRIENN CSERHÁTI, JUDIT OLÁH, DÁVID KIS, PÁL BARZÓ, KATALIN HIDEGHÉTY
Anticancer Research Aug 2020, 40 (8) 4237-4244; DOI: 10.21873/anticanres.14425
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Risk Factors for Sleep Problems Prior to Radiochemotherapy for Malignant Gliomas
  • Alpha-type-1 Polarized Dendritic Cell-based Vaccination in Newly Diagnosed High-grade Glioma: A Phase II Clinical Trial
  • Targeted Genomic Sequencing Reveals Different Evolutionary Patterns Between Locally and Distally Recurrent Glioblastomas
  • Google Scholar

More in this TOC Section

  • Antiemetic Efficacy of Aprepitant in Cisplatin–Gemcitabine Therapy for Biliary Tract Cancer: A Multicenter Study
  • Prognostic and Neurological Outcomes Following Surgery for Spinal NF2-Associated Ependymomas With Cysts
  • Prior Chlamydia trachomatis Infection and the Risk of Epithelial Ovarian Cancer and Borderline Ovarian Tumors
Show more Clinical Studies

Keywords

  • adaptive radiotherapy
  • replanning
  • Gliomas
  • brain tumor
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire